Hepagene (Shanghai) Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Hepagene (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study of HPG1860 in Subjects With NASH (NCT05338034) | Hepagene (Shanghai) Co., Ltd. | 2021-11-22 |
| Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects (NCT04480697) | Hepagene (Shanghai) Co., Ltd. | 2019-09-23 |
Track Hepagene (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.